Robert Wolff
Managing Director @Kleijnen Systematic Reviews Ltd
Signup · Get unlimited contacts
WORK HISTORY
Managing Director @Kleijnen Systematic Reviews Ltd
York, GB
In addition to working as a Reviews Manager, responsible for the day-to-day to business.
EDUCATION
Integrierte Gesamtschule Neumünster
Abitur (A-levels)
The University of Freiburg
Dr. med., Medicine
Die Johanniter
Paramedic
Freie Universität Berlin
Medicine
SKILLS
ABOUT ROBERT WOLFF
Physician and scientist working in the field of evidence-based medicine and evidence-based healthcare. Managing Director of Kleijnen Systematic Reviews Ltd, a National Institute for Health Research (NIHR) Technology Assessment Reviews (TAR) research team.Special interest in systematic reviews, health technology assessments, clinical guidelines and shared decision making as well as methodological aspects of risk of bias assessment. Member of the steering group for PROBAST, a tool to assess the risk of bias and applicability of diagnostic and prognostic prediction models.Involved in the development and maintenance of KSR Evidence, a database of systematic reviews in healthcare.Member of the leadership team of the LATITUDES Network.Selected publications- Danner M, Debrouwere M, Rummer A, Wehkamp K, Rüffer JU, Geiger F, Wolff R, Weik K, Scheibler F. A scattered landscape: assessment of the evidence base for 71 patient decision aids developed in a hospital setting. BMC Med Inform Decis Mak 2022;22:44- Kreuzberger N, Damen JAAG, Trivella M, Estcourt LJ, Aldin A, Umlauff L, Vazquez-Montes MDLA, Wolff R, Moons KG, Monsef I, Foroutan F, Kreuzer K-A, Skoetz N. Prognostic models for newly‐diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta‐analysis. Cochrane Database of Systematic Reviews 2020, Issue 7. Art. No: CD012022. DOI: 10.1002/14••••58.CD012022.pub2- Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S, PROBAST Group. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med 2019;170(1):51-58- Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med 2019;170(1):W1-W33- Whiting P, Wolff R, Mallett S, Simera I, Savovic J. A proposed framework for developing quality assessment tools. Syst Rev 2017;6:204- Contributed to various evidence reports for share-to-care (https://share-to-care.de), a project supporting shared decision making (SDM) in Germany- Contributed to various health technology assessments for National Institute for Health and Care Excellence (NICE) and Institute for Quality and Efficiency in Healthcare (IQWiG)
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.